Infectious Disease Update: Clinical Pearls
Ted Rosen, MD
At MauiDerm Fall NP+PA 2014, Dr Rosen provides us with an update on infectious diseases and his clinical pearls…
- STDs are globally epidemic. In the US, 50% of those 15-25 have or have had an STD
- STDs are so common due to the “multiplier” effect of sex partners of sex partners
- Syphilis is on the rise last three years in USA, now at 5.3/100,000 population
- Multi-drug resistant GC (including resistance to drugs of choice, cephalosporins) is here
- Topical three months regimen of 4% zinc sulfate soaks for active genital herpes benficial
- External genital warts: NEW treatment ideas
- 5% KOH daily x 3 months
- Single application of ingenol mebutate (either strength)
- Thermotherapy with 440C for 30 min x 3 days, each of two consecutive weeks
- Leishmaniasis being brought back to USA from Iraq and Afghanistan
- Rx: Pentavalent antimonial IV, IM from CDC; Quite toxic.
- Thermotherapy (ThermoMed device): 1300F; Painful and blisters
- New drug: Miltefosine 100-150mg/day PO (Impavido™) available 2015
- Lecithin derivative
- Safe and effective for Old and New World Leishmaniasis
- Treatments for MRSA have expanded with three new drugs
- All new drugs have LONG T1/2 which allows less frequent dosing
- Oritivancin: Single 1200mg dose
- Dalbavancin: 1000mg, then 500mg a week later
- Tedizolid: 200mg QD x 5-7 days
- Chikungunya virus
- Used to be Africa/Asia, Now worldwide
- Most cases imported from trip (especially from Caribbean)
- Now, virus-carrying mosquitoes in Caribbean and USA
- Fever, arthralgia, myalgia, headache, petechial to purpuric rash
- Like Dengue but not as bad
- No vaccination, No specific Rx. Supportive therapy, as needed.